December 22, 2021
BURLINGTON, Ontario – December 22, 2021- Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that the ongoing development of an orally delivered vaccine candidate for COVID-19 has received the final instalment of the Collaborative...
December 15, 2021
Additions to support immediate commercialization efforts for the Company’s COVID-19 vaccine candidate BURLINGTON, Ontario – December 15, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce a significant addition to...
December 9, 2021
BURLINGTON, Ontario – December 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland Health Limited (“Oakland Health” operating as “RD Therapeutics”) to...
November 30, 2021
BURLINGTON, Ontario – November 30, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has entered into a strategic business development agreement with AB Strategic Ventures (“ABSV”) with the purpose of supporting relationship building...
November 24, 2021
BURLINGTON, Ontario – November 24, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of one million QuickStrip™ units to one of Canada’s largest cannabis companies. Three unique formulations...
November 9, 2021
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis BURLINGTON, Ontario – November 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of more than 500,000...
October 1, 2021
FOR IMMEDIATE RELEASE RDT branded QuickSips™ and QuickStrip™ will be available in stores from coast-to-coast BURLINGTON, Ontario – October 1, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced the successful receipt...
September 28, 2021
Productive discussion regarding “made-in-Ontario COVID-19 vaccine candidate” BURLINGTON, Ontario – September 28, 2021- Yesterday afternoon, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) welcomed Premier Doug Ford and Caucus member Stephen Crawford MPP, to their head office and manufacturing facility in Burlington, Ontario...
September 15, 2021
Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario – September 15, 2021- Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are reporting a preliminary, yet significant milestone in the investigation of an orally...
August 26, 2021
FOR IMMEDIATE RELEASE BURLINGTON, Ontario – August 25, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), today reported its Q1 financial results. “The Company is on a path of transformation and is well-positioned to drive innovation and our business plan forward as...